14h
Hosted on MSNHow Chinese biotech firm BGI grew to rival US giant Illumina & enter US-China tariff warChina has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...
After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...
Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...
For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...
Illumina Protein Prep™, powered by SOMAmer® technology, a next-generation sequencing (NGS) based solution that will help scale access to proteomic insight Illumina, Inc. (NASDAQ:ILMN ...
Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform: London Saturday, February 1, 2025, 15:00 Hrs [IST] Angle plc, a wo ...
Over the last six months, ANGLE has overcome technical issues to successfully use Illumina assays, coupled with their next generation sequencing (NGS) platform, to provide a complete solution for ...
TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...
China’s Commerce Ministry this week said it placed Illumina, the leading maker of next-generation sequencing machines, on its list of “unreliable entities,” part of China’s retaliation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results